Ramos, Tania Crombet <br/><br/>
Treatment of NSCLC patients with an EGF-based cancer vaccine: report of a Phase I trial.  [electronic resource] 

 -  Cancer biology & therapy  Feb 2006 
 - 145-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1538-4047 
<br/><br/><label>Standard No.: </label>10.4161/cbt.5.2.2334  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies--blood<br/>Cancer Vaccines--adverse effects<br/>Carcinoma, Non-Small-Cell Lung--therapy<br/>Epidermal Growth Factor--blood<br/>Female<br/>Humans<br/>Immunotherapy, Active<br/>Lung Neoplasms--therapy<br/>Male<br/>Middle Aged